A new cancer vaccine has been developed by Professor Ray Iles of Middlesex University, which could kill some of the most aggressive forms of cancer.

The drug is administered as an injection and works by stopping cancer growth. The cancer vaccine is even capable of shrinking cancer tumours.

Human chorionic gonadotropin (hCG) is found in bladder, pancreatic, breast, bowel, ovarian and cervical cancers. The new cancer vaccine works by boosting the patient’s immune system and targeting the hCG, which stops the spread of the tumour. The spread of cancer tumours to other organs in the body is the greatest cause of death in cancer patients.

The new cancer vaccine is currently being tested on human patients and it could be available to all in the next few years. Tests on animals have already revealed impressive results.

The new cancer vaccine also affects women’s fertility, so for female cancer patients it could also be used as a contraceptive.

In the last 40 years, cancer survival rates have improved with the advances in medical research. Now patients that suffer from breast, bowel and ovarian cancer are more likely to survive.

Every year cancer claims thousands of lives and breast cancer is the most common form of the disease. Currently cancer care on the NHS isn’t as good as the care that patients receive in Europe. The new cancer vaccine could improve NHS cancer care and limit the number of deaths in the UK.